Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04165031
Title A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

Therapies

Cetuximab + LY3499446

Erlotinib + LY3499446

LY3499446

Abemaciclib + LY3499446

Docetaxel

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana Univ Melvin & Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Memorial Sloan Kettering Cancer Center Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Cancer Center Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10022 United States Details
St Vincent's Hospital Darlinghurst New South Wales 2010 Australia Details
Linear Clinical Research Ltd Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field